Editorial: Proteomics as a Tool for Biomarker and Drug Target Discovery: Improving the Diagnosis and Treatment of Neurodegenerative Diseases

Journal article

Open access

Peer reviewed

Olivia Belbin, Sylvain Lehmann, Eduard Sabidó and Christophe Hirtz

Frontiers in Aging Neuroscience, Vol.12

26/11/2020

PMCID: PMC7726015

PMID: 33324192

Abstract

Alzheimer's disease

Parkinson's disease

amyotrophic lateral sclerosis

biomarker

drug targets

frontotemporal dementia

neurodegenerative diseases

proteomics

url

Find in HALView

url

https://doi.org/10.3389/fnagi.2020.00232View

Published (Version of record) Open

1 Record Views

Title: Editorial: Proteomics as a Tool for Biomarker and Drug Target Discovery: Improving the Diagnosis and Treatment of Neurodegenerative Diseases
Creators - without role: Olivia Belbin - Biomedical Research Institute
Sylvain Lehmann - Université de Montpellier, Cell souches plasticité cellul régénérat tissulaire immuno des maladies inflamm - IRMB
Eduard Sabidó - Pompeu Fabra University
Christophe Hirtz - Université de Montpellier, Cell souches plasticité cellul régénérat tissulaire immuno des maladies inflamm - IRMB
Publication Details: Frontiers in Aging Neuroscience, Vol.12
Identifiers: 9943881609311
Academic Unit: Cell souches plasticité cellul régénérat tissulaire immuno des maladies inflamm - IRMB; Institut des Neurosciences de Montpellier - INM
Language: English
Resource Type: Journal article
Local Fields: hal-03177444